On February 15-16, 2025, the “Robotic Biliary Surgery Symposium: Collision and Integration of Da Vinci and Domestic Robots” was successfully held in Guiyang, gathering over 30 leading experts and 23 renowned institutions worldwide. The event showcased the latest robotic applications in biliary surgery through live streaming and in-person exchanges.
A highlight was Director Zhe Wen from Guangzhou Women and Children’s Medical Center performing a pediatric single-port robotic choledochal cyst excision using the SHURUI® single-port surgical robot. This two-hour, virtually bloodless surgery through a transumbilical single-port approach demonstrated remarkable precision and minimal scarring. The live broadcast attracted nearly 20,000 viewers, spotlighting the innovative capabilities of China’s domestic single-port robotic technology in pediatric biliary surgery.
Professor Wen emphasized the SHURUI® robot’s superior surgical exposure, precise suturing under 10x 3D magnification, and stable hemostasis. This breakthrough not only validates the feasibility of single-port robotic biliary surgery in children but also paves the way for broader clinical adoption and future innovations.
Important Notes
The SHURUI Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has obtained the CE marking for urologic laparoscopic surgical procedures, gynecologic laparoscopic surgical procedures, general laparoscopic surgical procedures, and thoracoscopic surgical procedures. It is intended for use by trained surgeons in an operating room environment in accordance with the representative, specific procedures set forth in the User Manual.
Safety and Performance Information
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other trademarks and may not be used without permission.
